Comments
Shares of drugmaker Wockhardt Ltd rise as much as 2.3 per cent to Rs 460, their highest since April 8. The company says no observations made after US FDA inspects its Bioequivalence centre in Aurangabad, Maharashtra.
Bioequivalence studies of Tamsulosin 0.4mg capsules and Metoprolol Tartrate 200mg ER tablets were audited, the company had reported. About 425,970 shares change hands in less than half an hour into trading compared with the 30-day average volume of around 1.9 million.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.